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Conclusion    Radiation-induced microbleeds occurred 
more frequently in the present study than has been pre-
viously reported. PSI can be used to detect these vascu-
lar changes earlier than other conventional MR imaging 
techniques. 
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Radiation therapy is an efficacious treatment for brain 
neoplasms. However, cranial irradiation can cause com-
plications as well as benefits. Complications of cranial 
irradiation include necrosis, diffuse white matter injury, 
central nervous system atrophy, mineralization, micro-
angiopathy, telangiectasia, optic neuropathy, and large 
vessel vasculopathy.1 Although clinically important 
complications are infrequent with modern radiation 
therapy techniques, asymptomatic complications fol-
lowing radiation therapy, such as diffuse white matter 
injury, central nervous system atrophy, and vascular in-
jury, can be present by follow-up computed tomography 
(CT) and magnetic resonance (MR) imaging. Radiation-
induced vascular injury can be classified into 2 types: 
large arterial injury and telangiectasia, or cryptic vas-
cular malformation. Radiation-induced telangiectasia 
in the brain results in varying amounts of hemorrhage 
and may have an appearance similar to that of cryptic 
vascular malformation.2 These lesions are usually small 
and can be mixed with cavernous malformation. As the 
differentiation of these small lesions is often difficult on 
MR imaging, we refer to these conditions as radiation-
induced microbleeds. Although there have been many 
reports concerning radiation-induced microbleeds in the 
past, the frequency, dose relation, and latency of radia-
tion-induced microbleeds are not fully elucidated.
 MR imaging is useful for diagnosis and evalua-
tion of these cerebral complications following radiation 
therapy.3 MR imaging is currently considered to be the 
best imaging technique for evaluation of brain injury 
following radiation therapy.4 Susceptibility-weighted im-
aging (SWI) is a 3-dimensional gradient echo MR imag-
ing technique using the blood oxygen level-dependent 
ABSTRACT
Background    Although there are many reports re-
garding radiation-induced microbleeds, its frequency, 
relation to dose and latency after radiation are not fully 
elucidated. The purpose of this study was to evaluate the 
frequency, latency, patient factors and dose relation of 
radiation-induced microbleeds after cranial irradiation 
using phase-sensitive magnetic resonance imaging (PSI) 
at 3.0 T. 
Methods    Retrospective evaluation of 34 patients (age 
range, 13–78 years; mean, 49 years; follow-up period, 
3–169 months; mean 29 months) who had undergone 
cranial irradiation using magnetic resonance (MR) 
imaging including PSI was performed. Twenty-three 
patients received high-dose irradiation (44–60 Gy), and 
11 patients received 24–30 Gy whole brain irradiation. 
When microbleeds were detected on MR imaging in 
these high-dose irradiation patients, dose distribution 
maps were reproduced by reviewing the clinical records. 
Then the irradiated areas were divided into 6 radiation-
dose classes: regions > 55 Gy, 45–55 Gy, 35–45 Gy, 
25–35 Gy, 15–25 Gy and 5–15 Gy. The frequency of 
microbleeds in each radiation-dose class was analyzed.. 
Results    Microbleeds were detected in 7 (21%) of 34 
patients on T2-weighted imaging, whereas they were 
detected in 16 (47%) of the 34 patients on PSIs. The 
frequency of microbleeds was higher than previously re-
ported. The latency of radiation-induced microbleeds af-
ter radiation was 3 months to 9 years (mean, 33 months). 
In high-dose irradiation patients, the frequency of mi-
crobleeds significantly was associated with radiation 
dose. There were no foci that were observed in regions 
that had received < 25 Gy. 
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effect.5 SWI is highly sensitive to differences of the 
magnetic susceptibility properties between tissues, such 
as blood products (including deoxyhemoglobin, methe-
moglobin and hemosiderin). T2*-weighted imaging is 
also considered to be a highly sensitive MR technique 
for visualization of cerebral hemorrhage. However, SWI 
is currently considered to be more sensitive than other 
conventional MR imaging techniques, including T2*-
weighted imaging, for detection of hemorrhage.6 Phase-
sensitive MR imaging (PSI), based on principles similar 
to those of SWI, is obtained by multiplication of the 
phase and magnitude images using Windows-based soft-
ware.
 The purpose of this study was to evaluate the fre-
quency, latency, patient factors, and dose relation of radi-
ation-induced microbleeds after cranial irradiation using 
PSI, and to evaluate the usefulness of PSI for detection 
of radiation-induced microbleeds.
 
 
MATERIALS AND METHODS
Patients
MR imaging and clinical records of 34 patients (18 men 
and 16 women; age range, 13–78 years; mean age, 49 
years) who had undergone brain irradiation and under-
gone MR imaging including PSI with a follow-up period 
of at least 3 months were retrospectively reviewed. The 
average follow-up period was 29 months (3–169 months).
Eleven patients received 24–30 Gy of whole brain irra-
diation. Eight of these patients had been diagnosed with 
brain metastases, 1 had been diagnosed with germinoma 
by biopsy, and 2 had received prophylactic cranial irradi-
ation for lung small cell carcinoma. Twenty-two patients 
received 44–60 Gy of localized brain irradiation, and 
1 patient received 60 Gy of opposing portal irradiation. 
These patients had undergone surgical resection or biop-
sy and diagnoses proved by their pathological diagnosis. 
The diagnoses included 17 high-grade gliomas, 2 central 
neurocytomas, 1 medulloblastoma, 1 meningioma, 1 
germinoma and 1 metastasis from occult primary can-
cer. When microbleeds were detected on MR imaging in 
patients who had received high-dose irradiation (44–60 
Gy), dose distribution maps were reproduced by review-
ing clinical records. Then, the area that had received 
irradiation was divided into 6 radiation-dose classes: 
regions with > 55 Gy, 45–55 Gy, 35–45 Gy, 25–35 Gy, 
15–25 Gy and 5–15 Gy. One patient who received 60 
Gy of opposing portal irradiation was regarded to have 
received > 55 Gy. Microbleeds were then evaluated in 
each radiation-dose class region.
 All 34 patients were divided into 2 groups by fac-
tors such as gender (male versus female), age (over 60 
years versus less than 60 years), hypertension (with ver-
sus without), and chemotherapy (done versus not done). 
Patient characteristics are summarized in Table 1. Age 
is defined as the patient’s age at the beginning of the ir-
radiation. Patients who had received medication for hy-
pertension were classified as having hypertension.
 
Brain radiation therapy
Eleven patients who received whole brain irradiation 
were treated with total doses between 24–30 Gy, at 2.0–
3.0 Gy dose per fraction. The treatment duration was 
2–2.4 weeks. The other 23 patients were treated with 
total doses between 44–60 Gy, at a dose of 1.8–2.0 Gy 
per fraction. The treatment duration was 4.4–6 weeks. 
A 6 MV-Xray was used (Clinic iX 4217, Varian Medical 
Systems, Palo Alto, CA; or Linac EXL-15SP Mitsubishi 
Electric, Tokyo, Japan) in all patients.
 
MR imaging 
Before and at least 3 months after completion of radia-
tion therapy, all patients underwent MR imaging. All 
Table l. Patient characteristics 
  
Number of patients  34
Gender Male  18
 Female 16
Age (yr) Range 13–78
 Mean 49
 Median 51
 60 and over 12
 Less than 60 22
Follow-up period (mo) Range 3–169
 Average 29
Irradiation Localized irradiation 22
 Opposing portal irradiation 1
 Whole brain irradiation 11
Total dose (Gy) Localized irradiation 44–60
 Opposing portal irradiation 60
 Whole brain irradiation 24–30
Number of fractions Localized irradiation 22–30
 Opposing portal irradiation 30
 Whole brain irradiation 10–12
Diagnosis High-grade gliomas 17
 Central neurocytomas 2
 Germinoma 2
 Medulloblastoma 1
 Meningioma 1
 Metastasis from occult primary cancer 1
 Brain metastases 8
 Prophylactic cranial irradiation
      for lung small cell carcinoma 2
Chemotherapy Done 30
 Not done 4
Hypertension Patient with hypertension 4
 Patient without hypertension 30
Serial imaging Available 21
 Not available 13
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MR brain images were obtained at 3.0 T (Signa EX-
CITE HD, General Electric, Milwaukee, WI) using an 
8-channel phased-array coil (USA Instruments, Aurora, 
OH), except for 1 patient. That patient was examined at 
1.5 T (Symphony, Siemens, Germany) prior to radiation 
therapy and was examined with the 3.0 T MR system 
mentioned above after radiation therapy. At 3.0 T, we ob-
tained axial T1-weighted images with and without intra-
venous gadopentetate dimeglumine (Magnevist; Bayer, 
Osaka, Japan) using a fast spoiled gradient recalled ac-
quisition in steady state (FSPGR) sequence, T2-weighted 
fast spin echo (FSE) images, and fluid attenuated inver-
sion recovery (FLAIR) images. The imaging parameters 
were as follows: FSPGR, repetition time (TR)/echo time 
(TE) of 9/2 ms, flip angle (FA) of 13 ,˚ 512 × 256 matrix, 
1 excitation, 21 cm field of view (FOV), bandwidth of 
122 Hz/pixel and a slice thickness of 1.4 mm without 
intersection gap; T2-weighted FSE, TR/TE of 4000/95 
ms, 512 × 320 matrix, 21 cm FOV, section thickness/
intersection gap of 5/1.5 mm; and FLAIR, TR/TE/inver-
sion time (TI) of 10,000/116/2500 ms, 384 × 192 matrix, 
21 cm FOV and a section thickness/intersection gap of 
5/1.5 mm. At 1.5 T, T1-weighted images with and with-
out contrast medium, T2-weighted images, and FLAIR 
images were obtained using similar sequences.
 PSI, on the basis of principles similar to those of 
SWI,7 was acquired after the radiation therapy using 
a 3-dimensional-spoiled gradient recalled acquisition 
steady state sequence with flow compensation using the 
following imaging parameters: TR/TE of 45/30 ms, FA 
of 20 ,˚ FOV of 21 cm, 512 × 192 matrix, section thick-
ness of 1.5 mm and an acquisition time of 7 min 40–50 
s. All images were obtained in the axial plane. PSI were 
post-processed using a high-pass filter and then the im-
ages were converted into negative phase masks that were 
multiplied 4 times into the corresponding magnitude im-
ages using research software (PSIRecon: GE Yokogawa 
Medical Systems, Tokyo). A minimum intensity projec-
tion was performed to display the processed data using 
contiguous 10-mm-thick sections with 7-mm overlap in 
the axial plane. The follow-up interval for the MR imag-
ing was dependent on the clinical course, and serial MR 
images including PSI were obtained in 21 patients after 
radiation therapy.
 
Image evaluation 
Microbleeds were determined to be present if a small 
focus of very low signal-intensity was recognized on PSI 
Fig. 1. A 31-year-old man with surgical resection of a high-grade glioma in the left parietal lobe, which was followed by localized irradia-
tion at a dose of 60 Gy.
A: PSI obtained 17 months after completion of radiation therapy.
B: PSI obtained 33 months after completion of radiation therapy. A hypointense focus that cannot be detected in A appears in the left 
parietal white matter in B (arrow). This focus can be interpreted as microbleed. 
C: T2-weighted image obtained 33 months after completion of radiation therapy. The microbleed detected in B cannot be detected.
D: Fused PSI image. The microbleed is contoured.
E: Reproduced dose distribution map. The microbleed is recognized in regions with > 55 Gy.
PSI, phase-sensitive magnetic resonance imaging.
A B C
D E
5500.0 cGy 
4500.0 cGy
3500.0 cGy
2500.0 cGy
1500.0 cGy 
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and/or T2-weighted imaging. The presence or absence of 
microbleeds was evaluated by 2 experienced neuroradi-
ologists. Areas of surgical intervention and calcifications 
were excluded by reviewing surgical records and subse-
quent CT performed within 1 month from MR imaging. 
Regions of metastasis or residual tumor were excluded 
by the combined inspection of T1-weighted images and 
contrast enhanced T1-weighted images. In cases with 
microbleeds found on MR imaging performed only once 
after radiation therapy, previously existing microbleeds 
(prior to irradiation) were excluded through comparison 
of previous MR images with MR images including PSI 
after radiation therapy. The final decision regarding the 
presence of microbleeds on MR imaging was made by 
means of mutual consent between 2 neuroradiologists. 
In patients who had received high-dose irradiation and 
who had detected microbleeds, PSI was fused to the 
dose distribution map. Then, the microbleed was evalu-
ated in each radiation-dose class region.
 
Statistical analyses 
To compare the detection rate of PSI and T2-weighted 
imaging, the Fisher exact test was used. The Fisher ex-
act test was used for comparisons between the groups, 
which were divided by several factors (including gender, 
age, hypertension and chemotherapy). In patients with 
microbleed in the high-dose irradiation group, Cochran-
Armitage trend test was used to identify appearance of 
microbleed associated with radiation dose. A P value < 
0.05 was considered to indicate statistical significance.
  
 
RESULTS
Microbleeds were detected in 7 (21%) of 34 patients on 
T2-weighted imaging, whereas they were detected in 
16 (47%) of the 34 patients on PSIs. A typical case of 
microbleed is shown in Fig. 1. There was a significant 
difference in detection of microbleeds in PSIs and T2-
weighted images (P  = 0.039, Fisher exact test). Mi-
crobleeds were found in 12 patients in the high-dose 
irradiation group, while they were found in 4 patients in 
the whole brain irradiation group. Five patients had 1 fo-
cus, and the other 11 patients had 2 or more foci. There 
were 45 foci in 15 patients, except 1 patient who had too 
many foci to count. Of the 16 patients with microbleeds, 
the appearance of microbleed was detected on the 2nd 
and/or 3rd follow-up PSI after radiation therapy in 11 
patients. In the remaining 5 patients, the appearance of 
microbleed was detected on the 1st PSI after radiation 
therapy. The 2 neuroradiologists concluded that these 
microbleeds developed after the radiation therapy on 
the basis of detailed comparison of T2-weighted images 
before and after radiation therapy and PSI after radiation 
therapy. No microbleeds disappeared during 3 to 169 
months after the end of radiation therapy.
 In the present study the latency period for radiation-
induced microbleeds was 3 months to 9 years. The mean 
and median latency periods in which microbleeds were 
first observed were 33 months and 19 months, respec-
tively. In 27 patients that were examined by PSI within 2 
years after radiation therapy, microbleeds were detected 
in 10 patients (37%).
 There was no statistically significant difference in 
the frequency of microbleeds between the groups, which 
were divided by gender (P = 0.74), age (P = 0.29), hyper-
tension (P = 1.0) and chemotherapy (P = 0.60). Results 
of comparison of each group are summarized in Table 2.
In 23 patients who received high-dose irradiation of 
44–60 Gy, 12 patients developed microbleeds. In these 
12 patients, frequency of microbleeds was significantly 
associated with radiation dose (P < 0.001, Cochran-
Armitage trend test). The frequency of microbleeds ac-
cording to the dose class is summarized in Table 3. No 
Table 2. Results of comparison between groups di-
vided by several factors
 Number of patients 
  With  Without
 Total microbleeds microbleeds P value
Gender    0.74†
 Male 18 9 9
 Female 16 7 9
Age*    0.29†
 60 and over 12 4 8
 Less than 60 22 12 10
Chemotherapy    0.60†
 Done 30 15 15
 Not done 4 1 3
Hypertension    1†
 With 4 2 2
 Without 30 15 15
*yr. 
†No significant difference between 2 groups with Fisher’s exact test.
Table 3. Results from 12 patients with high-dose irra-
diation with microbleeds according to radiation-dose 
classes 
Radiation   Number   Number of  Frequency of
dose class of regions with  microbleeds 
(Gy) regions microbleeds  (%)
 
Over 55 8 6 75
45–55 11 7 63.6
35–45 11 3 27.2
25–35 11 3 27.2
15–25 11 0 0
  5–15 11 0 0
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foci were observed in the regions that had received < 25 
Gy irradiation. 
 
 
DISCUSSION
The mechanism of radiation-induced brain injury is not 
yet fully understood.8 There is a considerable literature 
regarding the pathogenesis of such side effects. Various 
hypotheses emphasize vascular changes, a direct effect 
on glial cells and/or an immunological mechanism.9 
 A mechanism for vascular injury is as follows. In 
acute vascular injury, transient vasodilatation occurs 
with variable changes in capillary permeability that 
sometimes manifests as vasogenic edema.10.11 Changes 
in capillary permeability in response to radiation therapy 
to the central nervous system have been quantitated and 
found to entail specific variability in molecular sizes.12.13 
In chronic radiation-induced injury such as endothelial 
damage, vascular ectasia and microbleeds can occur. 
These changes result in increased capillary permeability 
at the site of vascular injury with resultant cytotoxic and 
vasogenic edema. Progressive vascular changes include 
vessel wall thickening with consequent thrombosis, in-
farction and necrosis.11 Results of these studies provide 
support for the concept that vascular injury plays a piv-
otal role in the development of radiation-induced brain 
injury.
 As noted above, radiation-induced vascular injury 
commonly affects small arteries and capillaries.14 In 
addition, less commonly progressive radiation-induced 
large vessel vasculopathy may occur. Intracerebral hem-
orrhage occasionally occurs as a late delayed reaction.15 
In an animal study, vascular abnormalities were shown 
to occur before the development of parenchymal chang-
es in the brain.16 Therefore, radiation-induced vascular 
alterations, as represented by microbleeds, should be 
evaluated in order to know the severity of brain injury.
 The frequency of radiation-induced telangiecta-
sia has been reported to be 20%.17 The frequency of 
radiation-induced microbleeds in the present study was 
higher than the frequency of telangiectasia, despite the 
short follow-up period. As PSI was acquired only once 
in the 5 patients with microbleeds, there is a possibility 
that the present study included patients with previously 
existing microbleeds. However, even after taking this 
possibility into account, the frequency is still higher than 
that of the previous reports. This may be because PSI is 
a highly sensitive technique for visualization of cerebral 
hemorrhage. SWI and PSI are currently recognized to 
be more sensitive than the other conventional MR imag-
ing techniques for detection of hemorrhage.6 In many 
previous reports, microbleeds were detected mainly 
in T2-weighted images. Therefore, many microbleeds 
might have been overlooked. In fact, the frequency of 
microbleeds in the present study in T2-weighted images 
was similar to the frequency of telangiectasia in previous 
reports. Therefore, it could be concluded that radiation-
induced microbleeds occur more frequently than has 
been previously assumed.
 The latency period of radiation-induced microbleeds 
has been reported on numerous occasions to have a wide 
range, between 5 months and 22 years.1 In the present 
study, the latency period was 3 months to 9 years. The 
latency period in the present study is similar to previous 
reports, but in general in the present study microbleeds 
appeared relatively early. Lupo et al recently reported 
using SWI with 7 T that 2 patients developed microbleed 
in the 5 patients within 2 years after radiation therapy.18 
In the present study, 10 patients developed microbleeds 
in the 27 patients within 2 years after radiation therapy. 
This early appearance may be related to the high sensi-
tivity of PSI. 
 In general, complications of radiation therapy to the 
brain are dependent on total dose, patient age, underly-
ing disease and concomitant therapy.3 Patient factors 
such as gender, age, hypertension and chemotherapy 
seem to be unrelated to the appearance of telangiectasia. 
However, it is known that the immature brain is more 
sensitive to radiation than the adult brain.19 Koike et al. 
reported that radiation-induced telangiectasia occurs 
more frequently in younger patients.17 In the present 
study there were only 3 patients whose age was under 20 
years. If more pediatric patients were included, a signifi-
cant difference might have been seen. Investigation of a 
larger number of younger patients is therefore desired.
 To our knowledge, there have been no reports that 
have proven a dose predominance in radiation-induced 
microbleeds. In order to investigate the relationship be-
tween microbleeds and radiation dose, the irradiation 
areas were separated into 6 regions according to the 
radiation dose in 12 patients who received high-dose ra-
diation with microbleeds. Frequency of microbleeds was 
significantly associated with radiation dose in the pres-
ent report. In previous reports, telangiectasias have de-
veloped in patients who received radiation doses ranging 
from 18 to 78 Gy.2, 20 In the present study there were no 
foci that were observed in regions that had received less 
than 25 Gy. The radiation dose threshold for develop-
ment of microbleed is still not clear. To our knowledge, 
there is no report of radiation-induced microbleed with a 
dose lower than 18 Gy. With low radiation doses, micro-
bleed may be less likely to develop. However, the present 
report suggests that vascular injury may occur around 
25 Gy. PSI can be used to detect these vascular changes 
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earlier than other conventional MR imaging techniques.
 There are several limitations to the present study. 
First, this study lacks histopathologic confirmation of 
all cases. Second, PSI before irradiation was not avail-
able; however, exclusion of calcification and microbleeds 
before irradiation was attempted in comparing previous 
MR and subsequent CT images. Lastly, the short obser-
vation period and the irradiation volume effect were not 
taken into consideration. 
The authors declare no conflict of interest.
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